WRAL story highlights bladder cancer vaccine study at UNC

A story that ran on Raleigh-based CBS affiliate WRAL focuses on a new bladder cancer vaccine being studied at UNC, called Impact Therapy. The vaccine works to target cancer cells with minimal side effects.

The University of North Carolina at Chapel Hill is the only trial in North Carolina for the vaccine. There are five active study sites across the country. 

Read more on WRAL's website External Site